Dasatinib in combination with BMS-754807 induce synergistic cytotoxicity in lung cancer cells through inhibiting lung cancer cell growth, and inducing autophagy as well as cell cycle arrest at the G1 phase

Wang M, Herbst RS, Boshoff C (2021) Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med 27(8):1345–1356

Article  CAS  PubMed  Google Scholar 

Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS et al (2022) Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20(5):497–530

Article  PubMed  Google Scholar 

Bade BC, Dela Cruz CS (2020) Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 41(1):1–24

Article  PubMed  Google Scholar 

Boumahdi S, de Sauvage FJ (2020) The great escape: tumour cell plasticity in resistance to targeted therapy. Nat Rev Drug Discov 19(1):39–56

Article  CAS  PubMed  Google Scholar 

Shen J, Li L, Yang T, Cohen PS, Sun G (2020) Biphasic mathematical model of cell-drug interaction that separates target-specific and off-target inhibition and suggests potent targeted drug combinations for multi-driver colorectal cancer cells. Cancers (Basel) 12(2):436

Article  CAS  PubMed  Google Scholar 

Alkebsi L, Wang X, Ohkawara H, Fukatsu M, Mori H, Ikezoe T (2021) Dasatinib induces endothelial-to-mesenchymal transition in human vascular-endothelial cells: counteracted by cotreatment with bosutinib. Int J Hematol 113(3):441–455

Article  CAS  PubMed  Google Scholar 

Liu C, Zhu X, Jia Y, Chi F, Qin K, Pei J, Zhang C et al (2021) Dasatinib inhibits proliferation of liver cancer cells, but activation of Akt/mTOR compromises dasatinib as a cancer drug. Acta Biochim Biophys Sin (Shanghai) 53(7):823–836

Article  CAS  PubMed  Google Scholar 

Huang WC, Kuo KT, Wang CH, Yeh CT, Wang Y (2019) Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway. J Exp Clin Cancer Res 38(1):180

Article  PubMed  PubMed Central  Google Scholar 

Hsu PC, Yang CT, Jablons DM, You L (2020) The crosstalk between src and Hippo/YAP signaling pathways in non-small cell lung cancer (NSCLC). Cancers (Basel) 12(6):1361

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan PD, Narzisi G, Jayaprakash AD, Venturini E, Robine N, Smibert P, Germer S et al (2018) YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proc Natl Acad Sci U S A 115(26):E6030–E6038

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fuentes-Baile M, Ventero MP, Encinar JA, García-Morales P, Poveda-Deltell M, Pérez-Valenciano E, Barberá VM et al (2020) Differential effects of IGF-1R small molecule tyrosine kinase inhibitors BMS-754807 and OSI-906 on human cancer cell lines. Cancers (Basel) 12(12):3717

Article  CAS  PubMed  Google Scholar 

Xue L, Chen F, Yue F, Camacho L, Kothapalli S, Wei G, Huang S et al (2021) Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer. Breast Cancer Res Treat 185(1):73–84

Article  CAS  PubMed  Google Scholar 

Zeng B, Liao X, Liu L, Zhang C, Ruan H, Yang B (2021) Thyroid hormone mediates cardioprotection against postinfarction remodeling and dysfunction through the IGF-1/PI3K/AKT signaling pathway. Life Sci 267:118977

Article  CAS  PubMed  Google Scholar 

Franks SE, Jones RA, Briah R, Murray P, Moorehead RA (2016) BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549. BMC Res Notes 9:134

Article  PubMed  PubMed Central  Google Scholar 

Dong AQ, Kong MJ, Ma ZY, Qian JF, Xu XH (2007) Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int 31(5):500–507

Article  CAS  PubMed  Google Scholar 

Reinmuth N, Kloos S, Warth A, Risch A, Muley T, Hoffmann H, Thomas M et al (2014) Insulin-like growth factor 1 pathway mutations and protein expression in resected non-small cell lung cancer. Hum Pathol 45(6):1162–1168

Article  CAS  PubMed  Google Scholar 

Siddle K (2011) Signalling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol 47(1):R1–10

Article  CAS  PubMed  Google Scholar 

Lehman CE, Spencer A, Hall S, Shaw JJP, Wulfkuhle J, Petricoin EF, Bekiranov S et al (2021) IGF1R and src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK. Sci Rep 11(1):10826

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen J, Li L, Yang T, Cheng N, Sun G (2019) Drug sensitivity screening and targeted pathway analysis reveal a multi-driver proliferative mechanism and suggest a strategy of combination targeted therapy for colorectal cancer cells. Molecules 24(3):623

Article  PubMed  PubMed Central  Google Scholar 

Awasthi N, Zhang C, Ruan W, Schwarz MA, Schwarz RE (2012) BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer. Mol Cancer Ther 11(12):2644–2653

Article  CAS  PubMed  Google Scholar 

Camidge DR, Otterson GA, Clark JW, Ignatius Ou SH, Weiss J, Ades S, Shapiro GI et al (2021) Crizotinib in patients with MET-amplified NSCLC. J Thorac Oncol 16(6):1017–1029

Article  CAS  PubMed  Google Scholar 

Chen Z, Chen Q, Cheng Z, Gu J, Feng W, Lei T, Huang J et al (2020) Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1. Cell Death Dis 11(10):858

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Li W et al (2020) PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11(9):797

Article  PubMed  PubMed Central  Google Scholar 

Nepstad I, Hatfield KJ, Grønningsæter IS, Reikvam H (2020) The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells. Int J Mol Sci 21(8):2907

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan AC (2020) Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac Cancer 11(3):511–518

Article  PubMed  PubMed Central  Google Scholar 

Bostner J, Karlsson E, Pandiyan MJ, Westman H, Skoog L, Fornander T, Nordenskjöld B et al (2013) Activation of akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit. Breast Cancer Res Treat 137(2):397–406

Article  CAS  PubMed  Google Scholar 

Lee S, Rauch J, Kolch W (2020) Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci 21(3):1102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drosten M, Barbacid M (2020) Targeting the MAPK pathway in KRAS-driven tumors. Cancer Cell 37(4):543–550

Article  CAS  PubMed  Google Scholar 

Martínez-Alonso D, Malumbres M (2020) Mammalian cell cycle cyclins. Semin Cell Dev Biol 107:28–35

Article  PubMed  Google Scholar 

Hume S, Dianov GL, Ramadan K (2020) A unified model for the G1/S cell cycle transition. Nucleic Acids Res 48(22):12483–12501

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levy JMM, Towers CG, Thorburn A (2017) Targeting autophagy in cancer. Nat Rev Cancer 17(9):528–542

Article  CAS  PubMed  Google Scholar 

Li X, Yang KB, Chen W, Mai J, Wu XQ, Sun T, Wu RY et al (2021) CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression. Autophagy 17(12):4323–4340

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia R, Bonifacino JS (2021) The ubiquitin isopeptidase USP10 deubiquitinates LC3B to increase LC3B levels and autophagic activity. J Biol Chem 296:100405

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen W, Li X, Yin M, Wang H, Qin L, Li H, Liu W et al (2021) Selective autophagy receptor SQSTM1/ p62 inhibits Seneca Valley virus replication by targeting viral VP1 and VP3. Autophagy 17(11):3763–3775

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harrison PT, Vyse S, Huang PH (2020) Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Semin Cancer Biol 61:167–179

Article 

留言 (0)

沒有登入
gif